Published in Anal Biochem on October 01, 1984
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging (2007) 2.31
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Eur J Nucl Med Mol Imaging (2009) 2.01
Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proc Natl Acad Sci U S A (1991) 1.52
PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab. J Nucl Med (2012) 1.38
Antibodies with infinite affinity. Proc Natl Acad Sci U S A (2001) 1.30
Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur J Nucl Med Mol Imaging (2007) 1.26
Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability. Bioconjug Chem (2012) 1.17
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. Nucl Med Biol (2010) 1.13
Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals. Dalton Trans (2011) 1.11
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas. Nucl Med Biol (2013) 1.08
Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis. Mol Imaging Biol (2012) 0.99
Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials (2013) 0.99
Macrocyclic chelates of radiometals for diagnosis and therapy. Br J Cancer Suppl (1990) 0.93
PET imaging of acute and chronic inflammation in living mice. Eur J Nucl Med Mol Imaging (2007) 0.90
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice. Br J Cancer (1994) 0.88
Rates and equilibria for probe capture by an antibody with infinite affinity. Bioconjug Chem (2010) 0.86
ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. Mol Pharm (2016) 0.82
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts. Cancer Immunol Immunother (2009) 0.81
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. Br J Cancer (2003) 0.80
CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Theranostics (2016) 0.80
Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibody. Inflamm Bowel Dis (2010) 0.79
Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Mol Pharm (2014) 0.79
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)Zr-immuno-PET. Eur J Nucl Med Mol Imaging (2016) 0.78
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2. Br J Pharmacol (2013) 0.78
A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy. Proc Natl Acad Sci U S A (1991) 0.78
Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. Am J Nucl Med Mol Imaging (2015) 0.78
A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment. Br J Cancer (1999) 0.76
Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics. Methods (2011) 0.75
Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy. J Labelled Comp Radiopharm (2013) 0.75
Preparation & in vitro evaluation of (90) Y-DOTA-rituximab. Indian J Med Res (2016) 0.75
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma. Oncoimmunology (2017) 0.75
The intrinsic curvature of DNA in solution. J Mol Biol (1988) 2.03
RNA contacts subunits IIo and IIc in HeLa RNA polymerase II transcription complexes. J Biol Chem (1986) 1.80
Thermal environment and sudden infant death syndrome: case-control study. BMJ (1992) 1.70
Positioning of two alpha subunit carboxy-terminal domains of RNA polymerase at promoters by two transcription factors. Proc Natl Acad Sci U S A (1997) 1.56
Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. Gastroenterology (1983) 1.54
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. Proc Natl Acad Sci U S A (1991) 1.52
Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci U S A (2000) 1.49
Ultrasonography and indium 111 white blood cell scanning for the detection of intraabdominal abscesses. Radiology (1981) 1.48
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J Nucl Med (1991) 1.46
Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins. Proc Natl Acad Sci U S A (2001) 1.45
The ventilatory lung scan in the diagnosis of pulmonary embolism. N Engl J Med (1970) 1.44
Diffusion-enhanced fluorescence energy transfer. Annu Rev Biophys Bioeng (1982) 1.41
Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. Anal Biochem (1985) 1.33
Topography of transcription: path of the leading end of nascent RNA through the Escherichia coli transcription complex. Proc Natl Acad Sci U S A (1983) 1.32
Antibodies with infinite affinity. Proc Natl Acad Sci U S A (2001) 1.30
Copper-64-labeled antibodies for PET imaging. J Nucl Med (1992) 1.29
Antibodies against metal chelates. Nature (1985) 1.27
Zinc is associated with the beta subunit of DNA-dependent RNA polymerase of Bacillus subtilis. Biochemistry (1977) 1.27
Directed hydroxyl radical probing of 16S rRNA using Fe(II) tethered to ribosomal protein S4. Proc Natl Acad Sci U S A (1995) 1.27
Peak density and distribution of ganglion cells in the retinae of microchiropteran bats: implications for visual acuity. Brain Behav Evol (1988) 1.25
Synthesis of the protein cutting reagent iron (S)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetate and conjugation to cysteine side chains. Bioconjug Chem (1997) 1.22
Indium-111-labeled autologous platelets for location of vascular thrombi in humans. J Nucl Med (1978) 1.21
Advances in pretargeting biotechnology. Biotechnol Adv (2001) 1.21
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med (1995) 1.21
Electrostatic field around cytochrome c: theory and energy transfer experiment. Proc Natl Acad Sci U S A (1990) 1.20
The two alpha subunits of Escherichia coli RNA polymerase are asymmetrically arranged and contact different halves of the DNA upstream element. Proc Natl Acad Sci U S A (1997) 1.19
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. J Nucl Med (1988) 1.17
Synthesis of a cleavable dinucleotide photoaffinity probe of ribonucleic acid polymerase: application to trinucleotide labeling of an Escherichia coli transcription complex. Biochemistry (1983) 1.16
Mapping the sigma70 subunit contact sites on Escherichia coli RNA polymerase with a sigma70-conjugated chemical protease. Proc Natl Acad Sci U S A (1998) 1.16
Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med (1988) 1.16
Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymerase. J Biol Chem (1999) 1.13
Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. J Nucl Med (1995) 1.13
A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer (1994) 1.09
Nerve growth factor and other agents mediate phosphorylation and activation of tyrosine hydroxylase. A convergence of multiple kinase activities. J Biol Chem (1985) 1.09
Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation (2000) 1.08
Positioning of sigma(S), the stationary phase sigma factor, in Escherichia coli RNA polymerase-promoter open complexes. EMBO J (1999) 1.07
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res (1995) 1.06
Protein-protein interactions mapped by artificial proteases: where sigma factors bind to RNA polymerase. Trends Biochem Sci (2000) 1.05
A study of alcoholism in half siblings. Am J Psychiatry (1972) 1.05
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. Proc Natl Acad Sci U S A (1997) 1.04
Binding of the sigma 70 protein to the core subunits of Escherichia coli RNA polymerase, studied by iron-EDTA protein footprinting. Proc Natl Acad Sci U S A (1996) 1.03
Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA. J Med Chem (1974) 1.03
The use of indium-111-labeled leukocytes for abscess detection. Clin Nucl Med (1978) 1.02
Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjug Chem (1991) 1.02
Mapping the promoter DNA sites proximal to conserved regions of sigma 70 in an Escherichia coli RNA polymerase-lacUV5 open promoter complex. Biochemistry (1998) 1.01
A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes. Nucleic Acids Res (1995) 1.01
Serum stability of 67Cu chelates: comparison with 111In and 57Co. Int J Rad Appl Instrum B (1986) 1.00
Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. Nucl Med Biol (1999) 0.99
Diffusion-enhanced lanthanide energy-transfer study of DNA-bound cobalt(III) bleomycins: comparisons of accessibility and electrostatic potential with DNA complexes of ethidium and acridine orange. Biochemistry (1985) 0.99
A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability. Nucleic Acids Res (1992) 0.99
Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins. Eur J Nucl Med (1984) 0.98
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med (1990) 0.97
Photoaffinity labeling of RNA polymerase III transcription complexes by nascent RNA. J Biol Chem (1990) 0.95
Synthesis of novel 1,4,7-triazacyclononane-N,N',N"-triacetic acid derivatives suitable for protein labeling. Bioconjug Chem (1992) 0.95
67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. Clin Cancer Res (1999) 0.94
Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J Nucl Med (1987) 0.94
Distribution of ions around DNA, probed by energy transfer. Proc Natl Acad Sci U S A (1986) 0.93
The study of biological macromolecules using perturbed angular correlations of gamma radiation. Cold Spring Harb Symp Quant Biol (1972) 0.93
Macrocyclic chelates of radiometals for diagnosis and therapy. Br J Cancer Suppl (1990) 0.93
Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma. J Nucl Med (2001) 0.93
Attachment of fluorescent metal chelates to macromolecules using "bifunctional" chelating agents. Biochem Biophys Res Commun (1977) 0.93
Stable bifunctional chelates of metals used in radiotherapy. Cancer Res (1990) 0.93
Aircrew dosimetry using the Predictive Code for Aircrew Radiation Exposure (PCAIRE). Radiat Prot Dosimetry (2005) 0.92
Study of carbonic anhydrase using perturbed angular correlations of gamma radiation. Proc Natl Acad Sci U S A (1969) 0.92
Targeted protein footprinting: where different transcription factors bind to RNA polymerase. Biochemistry (1999) 0.92
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer (1994) 0.92
Comparison of codes assessing galactic cosmic radiation exposure of aircraft crew. Radiat Prot Dosimetry (2009) 0.92
The study of 111 In-labeled compounds in mice, using perturbed angular correlations of gamma radiations. Radiology (1972) 0.91
Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J Nucl Med (1998) 0.91
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. J Nucl Med (1992) 0.91
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer Res (1992) 0.91
Structural analysis of a reconstituted DNA containing three histone octamers and histone H5. J Mol Biol (1987) 0.90
Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. J Nucl Med (1998) 0.90
Proximity mapping the surface of a membrane protein using an artificial protease: demonstration that the quinone-binding domain of subunit I is near the N-terminal region of subunit II of cytochrome bd. Biochemistry (1995) 0.89
Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. J Nucl Med (1981) 0.89